BMO Capital Downgrades Onyx Pharmaceuticals (ONXX) to Market Perform

August 9, 2013 7:39 AM EDT Send to a Friend
BMO Capital downgraded Onyx Pharmaceuticals (NASDAQ: ONXX) from Outperform to Market Perform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login